SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-447711
Filing Date
2014-12-19
Accepted
2014-12-19 08:07:06
Documents
3
Period of Report
2014-12-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d840680d8k.htm 8-K 14239
2 EX-99.1 d840680dex991.htm EX-99.1 13099
3 GRAPHIC g840680g53w87.jpg GRAPHIC 11481
  Complete submission text file 0001193125-14-447711.txt   44431
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 141297647
SIC: 2835 In Vitro & In Vivo Diagnostic Substances